Impaired DNA methylation and its mechanisms in CD4+T cells of systemic lupus erythematosus

Journal of Autoimmunity

Volumn 41, Issue , 2013, Pages 92-99

  Zhang, Yiqun ^a   Zhao, Ming ^a   Sawalha, Amr H ^b   Richardson, Bruce ^b   Lu, Qianjin ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

DNA methylation; Systemic lupus erythematosus; T cells

Indexed keywords

AUTOANTIBODY; CD40 LIGAND; CD70 ANTIGEN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PERFORIN; TRANSCRIPTION FACTOR;

ANTIBODY PRODUCTION; CD4+ T LYMPHOCYTE; CHROMATIN STRUCTURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MODIFICATION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

CD4-POSITIVE T-LYMPHOCYTES; DNA METHYLATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; MODELS, GENETIC; MODELS, IMMUNOLOGICAL;

EID: 84875961571     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.01.005     Document Type: Review

References (101)

1. Pan Y., Sawalha A.H. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res 2009, 153:4-10.
2. Wolffe A.P., Matzke M.A. Epigenetics: regulation through repression. Science 1999, 286:481-486.
3. Kaplan M.J., Lu Q., Wu A., Attwood J., Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004, 172:3652-3661.
4. Lu Q., Kaplan M., Ray D., Zacharek S., Gutsch D., Richardson B. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002, 46:1282-1291.
5. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
6. Oelke K., Lu Q., Richardson D., Wu A., Deng C., Hanash S., et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004, 50:1850-1860.
7. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
8. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
9. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
10. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998, 19:219-220.
11. Bostick M., Kim J.K., Esteve P.O., Clark A., Pradhan S., Jacobsen S.E. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317:1760-1764.
12. Sharif J., Muto M., Takebayashi S., Suetake I., Iwamatsu A., Endo T.A., et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912.
13. Kimura H., Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem 2003, 278:4806-4812.
14. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
15. Balada E., Ordi-Ros J., Vilardell-Tarres M. DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1108:127-136.
16. Song F., Smith J.F., Kimura M.T., Morrow A.D., Matsuyama T., Nagase H., et al. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci U S A 2005, 102:3336-3341.
17. Blackledge N.P., Klose R. CpG island chromatin: a platform for gene regulation. Epigenetics 2011, 6:147-152.
18. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev 2011, 25:1010-1022.
19. Razin A., Riggs A.D. DNA methylation and gene function. Science 1980, 210:604-610.
20. Bell A.C., Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000, 405:482-485.
21. Mancini D.N., Singh S.M., Archer T.K., Rodenhiser D.I. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 1999, 18:4108-4119.
22. Renda M., Baglivo I., Burgess-Beusse B., Esposito S., Fattorusso R., Felsenfeld G., et al. Critical DNA binding interactions of the insulator protein CTCF: a small number of zinc fingers mediate strong binding, and a single finger-DNA interaction controls binding at imprinted loci. J Biol Chem 2007, 282:33336-33345.
23. Zhu W.G., Srinivasan K., Dai Z., Duan W., Druhan L.J., Ding H., et al. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol 2003, 23:4056-4065.
24. Bogdanovic O., Veenstra G.J. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009, 118:549-565.
25. Robertson K.D. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610.
26. Richardson B., Scheinbart L., Strahler J., Gross L., Hanash S., Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990, 33:1665-1673.
27. Richardson B. Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum Immunol 1986, 17:456-470.
28. Corvetta A., Della Bitta R., Luchetti M.M., Pomponio G. 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases. J Chromatogr 1991, 566:481-491.
29. Hogg N., Laschinger M., Giles K., McDowall A. T-cell integrins: more than just sticking points. J Cell Sci 2003, 116:4695-4705.
30. Richardson B.C., Strahler J.R., Pivirotto T.S., Quddus J., Bayliss G.E., Gross L.A., et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 1992, 35:647-662.
31. Richardson B., Powers D., Hooper F., Yung R.L., O'Rourke K. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum 1994, 37:1363-1372.
32. Yung R., Powers D., Johnson K., Amento E., Carr D., Laing T., et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest 1996, 97:2866-2871.
33. Quddus J., Johnson K.J., Gavalchin J., Amento E.P., Chrisp C.E., Yung R.L., et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993, 92:38-53.
34. Luo Y., Li Y., Su Y., Yin H., Hu N., Wang S., et al. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br J Dermatol 2008, 159:827-833.
35. Voskoboinik I., Smyth M.J., Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006, 6:940-952.
36. Lu Q., Wu A., Ray D., Deng C., Attwood J., Hanash S., et al. DNA methylation and chromatin structure regulate T cell perforin gene expression. J Immunol 2003, 170:5124-5132.
37. Luo Y., Zhang X., Zhao M., Lu Q. DNA demethylation of the perforin promoter in CD4(+) T cells from patients with subacute cutaneous lupus erythematosus. J Dermatol Sci 2009, 56:33-36.
38. Denny M.F., Chandaroy P., Killen P.D., Caricchio R., Lewis E.E., Richardson B.C., et al. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol 2006, 176:2095-2104.
39. Blanco P., Pitard V., Viallard J.F., Taupin J.L., Pellegrin J.L., Moreau J.F. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2005, 52:201-211.
40. Arens R., Nolte M.A., Tesselaar K., Heemskerk B., Reedquist K.A., van Lier R.A., et al. Signaling through CD70 regulates B cell activation and IgG production. J Immunol 2004, 173:3901-3908.
41. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005, 174:6212-6219.
42. Sawalha A.H., Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur J Immunol 2007, 37:1407-1413.
43. Luo Y., Zhao M., Lu Q. Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus. Clin Exp Dermatol 2010, 35:425-430.
44. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591-594.
45. van Kooten C., Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000, 67:2-17.
46. Heard E., Disteche C.M. Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev 2006, 20:1848-1867.
47. Lockshin M.D. Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report. Lupus 2002, 11:662-666.
48. Zhou Y., Yuan J., Pan Y., Fei Y., Qiu X., Hu N., et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol 2009, 132:362-370.
49. Sawalha A.H., Wang L., Nadig A., Somers E.C., McCune W.J., Hughes T., et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J Autoimmun 2012, 38:J216-J222.
50. Sunahori K., Juang Y.T., Kyttaris V.C., Tsokos G.C. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J Immunol 2011, 186:4508-4517.
51. Mi X.B., Zeng F.Q. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol Sin 2008, 29:105-112.
52. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751.
53. Liu Y., Kuick R., Hanash S., Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009, 130:213-224.
54. Basu D., Liu Y., Wu A., Yarlagadda S., Gorelik G.J., Kaplan M.J., et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol 2009, 183:3481-3487.
55. Javierre B.M., Fernandez A.F., Richter J., Al-Shahrour F., Martin-Subero J.I., Rodriguez-Ubreva J., et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010, 20:170-179.
56. Jeffries M.A., Dozmorov M., Tang Y., Merrill J.T., Wren J.D., Sawalha A.H. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011, 6:593-601.
57. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000, 59:455-461.
58. Perez P., Goicovich E., Alliende C., Aguilera S., Leyton C., Molina C., et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 2000, 43:2807-2817.
59. Matache C., Stefanescu M., Dragomir C., Tanaseanu S., Onu A., Ofiteru A., et al. Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Autoimmun 2003, 20:323-331.
60. Chang Y.H., Lin I.L., Tsay G.J., Yang S.C., Yang T.P., Ho K.T., et al. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Biochem 2008, 41:955-959.
61. Ainiala H., Hietaharju A., Dastidar P., Loukkola J., Lehtimaki T., Peltola J., et al. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum 2004, 50:858-865.
62. Efthimiou P., Blanco M. Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod Rheumatol/Jpn Rheum Assoc 2009, 19:457-468.
63. Jiang Z., Sui T., Wang B. Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis. Rheumatol Int 2010, 30:1219-1226.
64. Liu Y., Zheng M., Yin W.H., Zhang B. [Relationship of serum levels of HGF and MMP-9 with disease activity of patients with systemic lupus erythematosus]. Zhejiang da xue xue bao Yi xue ban = J Zhejiang Univ Med Sci 2004, 33:340-343. 8.
65. Robak E., Wierzbowska A., Chmiela M., Kulczycka L., Sysa-Jedrejowska A., Robak T. Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus. Mediators Inflamm 2006, 2006:17898.
66. Cauwe B., Martens E., Sagaert X., Dillen C., Geurts N., Li S., et al. Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease. J Autoimmun 2011, 36:239-252.
67. Kurasawa K., Arai S., Owada T., Maezawa R., Kumano K., Fukuda T. Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus. Mod Rheumatol/Jpn Rheum Assoc 2010, 20:458-465.
68. Kuhl B.D., Sloan R.D., Donahue D.A., Bar-Magen T., Liang C., Wainberg M.A. Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology 2010, 7:115.
69. Thabet Y., Canas F., Ghedira I., Youinou P., Mageed R.A., Renaudineau Y. Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link?. J Autoimmun 2012, 39:154-160.
70. Kikuchi-Maki A., Yusa S., Catina T.L., Campbell K.S. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 2003, 171:3415-3425.
71. Hedberg A., Fismen S., Fenton K.A., Mortensen E.S., Rekvig O.P. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities. Exp Dermatol 2010, 19:e265-e274.
72. Tveita A.A., Rekvig O.P., Zykova S.N. Increased glomerular matrix metalloproteinase activity in murine lupus nephritis. Kidney Int 2008, 74:1150-1158.
73. Hu Y., Ivashkiv L.B. Costimulation of chemokine receptor signaling by matrix metalloproteinase-9 mediates enhanced migration of IFN-alpha dendritic cells. J Immunol 2006, 176:6022-6033.
74. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
75. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
76. Pan W., Zhu S., Yuan M., Cui H., Wang L., Luo X., et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010, 184:6773-6781.
77. Layer K., Lin G., Nencioni A., Hu W., Schmucker A., Antov A.N., et al. Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1. Immunity 2003, 19:243-255.
78. Zhao S., Wang Y., Liang Y., Zhao M., Long H., Ding S., et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011, 63:1376-1386.
79. Zhao S., Wang Y., Liang Y., Zhao M., Long H., Ding S., et al. MicroRNA-126 regulates DNA methylation in CD4(+) T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2010.
80. Qin H., Zhu X., Liang J., Wu J., Yang Y., Wang S., et al. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J Dermatol Sci 2012.
81. Gajiwala K.S., Chen H., Cornille F., Roques B.P., Reith W., Mach B., et al. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature 2000, 403:916-921.
82. Katan Y., Agami R., Shaul Y. The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucleic Acids Res 1997, 25:3621-3628.
83. Zhao M., Sun Y., Gao F., Wu X., Tang J., Yin H., et al. Epigenetics and SLE:RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun 2010, 35:58-69.
84. Zhao M., Wu X., Zhang Q., Luo S., Liang G., Su Y., et al. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res Ther 2010, 12:R227.
85. Deng C., Yang J., Scott J., Hanash S., Richardson B.C. Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem 1998, 379:1113-1120.
86. Deng C., Kaplan M.J., Yang J., Ray D., Zhang Z., McCune W.J., et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001, 44:397-407.
87. Deng C., Lu Q., Zhang Z., Rao T., Attwood J., Yung R., et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 2003, 48:746-756.
88. Sawalha A.H., Jeffries M., Webb R., Lu Q., Gorelik G., Ray D., et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 2008, 9:368-378.
89. Strickland F.M., Hewagama A., Lu Q., Wu A., Hinderer R., Webb R., et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J Autoimmun 2012, 38:J135-J143.
90. Gorelik G., Fang J.Y., Wu A., Sawalha A.H., Richardson B. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 2007, 179:5553-5563.
91. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002, 416:865-869.
92. Gorelik G.J., Yarlagadda S., Richardson B.C. Protein kinase Cdelta oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum 2012, 64:2964-2974.
93. Barreto G., Schafer A., Marhold J., Stach D., Swaminathan S.K., Handa V., et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 2007, 445:671-675.
94. Jin S.G., Guo C., Pfeifer G.P. GADD45A does not promote DNA demethylation. PLoS Genet 2008, 4:e1000013.
95. Li Y., Zhao M., Yin H., Gao F., Wu X., Luo Y., et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum 2010, 62:1438-1447.
96. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
97. Branco M.R., Ficz G., Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 2012, 13:7-13.
98. Williams K., Christensen J., Helin K. DNA methylation: TET proteins-guardians of CpG islands?. EMBO Rep 2012, 13:28-35.
99. Wu H., Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 2011, 25:2436-2452.
100. Xu Y., Xu C., Kato A., Tempel W., Abreu J.G., Bian C., et al. Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development. Cell 2012, 151:1200-1213.
101. Selmi C., Leung P.S., Sherr D.H., Diaz M., Nyland J.F., Monestier M., et al. Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J Autoimmun 2012, 39:272-284.